Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

The Importance of Tibial Artery Patency in the Rechanneling of the Femoral Artery

After rechanneling occluded superficial femoro-popliteal arteries, interventional physicians are left with the question of how to proceed with infrapopliteal disease. This work (soon to be published in Eur J Vasc Endovasc Surg) shows us the importance of achieving patency in tibial arteries so as to obtain better mid-term outcomes.

The gist is that, after an effort to rechannel a long, calcified chronic total occlusion in the superficial femoral artery, we must take a deep breath and make the same effort for the tibial arteries; otherwise, the job will be simply half way through.

 

This study included a total of 238 lower limbs in 199 patients with de novo superficial femoral artery chronic total occlusions treated with conventional nitinol stents between 2009 and 2015. These lower limbs were divided into 2 groups, group A (number of patent tibial arteries at baseline angiogram ≥2, 127 limbs in 104 patients) vs. group B (number of patent tibial arteries at baseline angiogram ≤1, 111 limbs in 95 patients).


Read also: Can We Discontinue Betablockers after AMI?


The additional efficacy of tibial artery patency after rechanneling the superficial femoral artery was evaluated by comparing B group subgroups (group B with patent tibial artery vs. without patent tibial artery). The primary endpoint was freedom from major events in the treated limb at 2 years, defined as a composite of repeat revascularisation and amputation.

 

Group A had a significantly higher event-free survival rate at 2 years compared with group B (80.9% vs. 43.5%; p < 0.001). This difference was mainly driven by the revascularization rate.


Read also: Less Bivalirudin and Minimal Use of Ultrasound for Puncture Is the Worldwide Trend in Transradial Access.


In the B group subgroup analysis, patients with tibial artery rechanneling (besides femoral artery rechanneling) had significantly higher event-free survival rates compared with patients who only underwent femoral artery rechanneling (65.5% vs. 26.2%; p = 0.001).

 

Conclusion

The presence of patent tibial arteries was an important predictor of events after the rechanneling of femoral arteries. Additional tibial artery angioplasty after femoral artery rechanneling is fundamental for the improvement of clinical outcomes.

 

Original title: The Importance of Patency of Tibial Run Off Arteries on Clinical Outcomes After Stenting for Chronic Total Occlusions in the Superficial Femoro-Popliteal Artery.

Reference: Yusuke Watanabe et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...